Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });

2022-11-26 HKT 09:22

Share this story

facebook

  • Omicron boosters available from next month

Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.

The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.

"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."

Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.

The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.

The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.

mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.

RECENT NEWS

SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion

SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more

4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA

The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more

Ripple Launches RLUSD Stablecoin In Japan Through SBI Group

Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more

SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan

SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more

Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences

Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more

European And South Korean Banks Form Project Pangea For FX Settlement

Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more